首页> 外文期刊>The Open Microbiology Journal >Programmatic Impact of Implementing GeneXpert MTB/ RIF Assay for the Detection of Mycobacterium Tuberculosis in Respiratory Specimens from Pulmonary Tuberculosis Suspected Patients in Resource Limited Laboratory Settings of Eastern Nepal
【24h】

Programmatic Impact of Implementing GeneXpert MTB/ RIF Assay for the Detection of Mycobacterium Tuberculosis in Respiratory Specimens from Pulmonary Tuberculosis Suspected Patients in Resource Limited Laboratory Settings of Eastern Nepal

机译:在尼泊尔东部资源有限的实验室中,实施GeneXpert MTB / RIF检测对肺结核疑似患者呼吸道标本中结核分枝杆菌的检测的计划影响

获取原文
           

摘要

Background:In Nepal, introduction of GeneXpert MTB/RIF assay (Xpert assay) as an initial confirmation test for tuberculosis (TB) has been considered to have impact as a significant decrease in number of clinically diagnosed pulmonary tuberculosis (PTB) cases than previous years. This study aims to find out the distribution profile of suspected tuberculosis cases according to patients age, gender, treatment history and HIV status as well as to evaluate the utility of the Xpert assay over conventional acid-fast bacilli (AFB) staining method for the proper diagnosis of M. Tuberculosis in respiratory specimens from the tuberculosis (TB) suspected patient samples. Methods:The prospective cross-sectional analytical study was conducted in National Anti-Tuberculosis Center (NATA) center- Biratnagar and Primary Healthcare Center (PHC) - Manglabare, Morang District, of eastern Nepal from January 2014 to August 2014. Laboratory investigation was done by conventional AFB staining followed by Xpert assay. Results:A total of 1549 sputum samples were initially analyzed. AFB staining resulted in 1441 AFB smear negative samples and 88 AFB smear positive samples, whereas 20 samples were directly processed for Xpert assay. The male: female smear positive ratio was 2.8:1 and was higher among age groups (21-40) years. Tuberculosis among HIV patients was found 22.22%. Xpert assay demonstrates that out of 1441 smear negative AFB cases, 258 were found to have TB positive, whereas out of 88 smears positive AFB cases 12 were found to have TB negative. The sensitivity of the Xpert assay in patients classified as AFB smear positive was found 85.4% and the specificity in smear negative patients was 81%. Conclusion:The study concluded that implementation of Gene Xpert MTB/RIF assay is a helpful tool for early and rapid detection of tuberculosis with greater sensitivity and specificity over traditional AFB staining techniques.
机译:背景:在尼泊尔,人们认为采用GeneXpert MTB / RIF测定法(Xpert测定法)作为结核病(TB)的初步确证试验,与过去几年相比,临床确诊的肺结核(PTB)病例数显着减少。这项研究旨在根据患者的年龄,性别,治疗史和艾滋病毒状况找出疑似结核病例的分布情况,并评估Xpert检测方法在常规抗酸杆菌(AFB)染色方法中的实用性。诊断疑似结核病患者的呼吸道标本中的结核分枝杆菌。方法:前瞻性横截面分析研究于2014年1月至2014年8月在尼泊尔东部莫兰区Manglabare的国家抗结核中心(NATA)中心-比拉德纳加尔和初级保健中心(PHC)-进行了实验室调查。通过传统的AFB染色,然后进行Xpert分析。结果:最初分析了总共1549痰标本。 AFB染色产生了1441个AFB涂片阴性样本和88个AFB涂片阳性样本,而直接处理20个样本进行Xpert分析。男性与女性的涂片阳性比率为2.8:1,并且在年龄段(21-40)岁之间较高。在艾滋病毒患者中发现结核病占22.22%。 Xpert分析表明,在1441例涂片阴性的AFB病例中,发现258例为结核阳性,而在88例涂片阳性的AFB病例中,发现12例为TB阴性。发现Xpert测定对AFB涂片阳性患者的敏感性为85.4%,在涂片阴性患者中的特异性为81%。结论:该研究结论认为,与传统的AFB染色技术相比,Gene Xpert MTB / RIF分析的实施是一种早期和快速检测结核病的有用工具,具有更高的灵敏度和特异性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号